Why Lenz Therapeutics Stock Crashed Today
Lenz Therapeutics (NASDAQ: LENZ) stock tumbled 11.2% through 9:50 a.m. ET Tuesday after missing on Q4 earnings.
Heading into the report, analysts forecast Lenz to lose $0.90 per share on quarterly sales of $3.1 million. Lenz lost $1.16 per share on sales of only $1.6 million.
Image source: Getty Images.
Source Fool.com
